Ajanta Pharma Limited — Others, 17-07-2025: Shareholders meeting

Ajanta Pharma recently concluded its 46th Annual General Meeting (AGM), held through video conference. Shareholders approved the adoption of the company's financial statements for the year ended March 31, 2025, and confirmed the interim dividend as the final dividend. Key leadership continuity was ensured with the approval of Mr. Rajesh M. Agrawal's re-appointment and Mr. Madhusudan B. Agrawal's re-appointment as Executive Director and Vice-Chairman. Additionally, the appointment of Secretarial Auditors and ratification of Cost Auditor remuneration were approved. The voting results from the AGM will be disclosed to exchanges shortly.